copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Niagen Bioscience, Formerly ChromaDex | The Leader in NAD+ Science Niagen Bioscience (formerly ChromaDex) is the premier leader in NAD+ research, clinical science, and ingredient innovation Our ISO-accredited labs and peer-reviewed publications establish us as the gold standard for NAD+ supplementation and NAD+ precursors, delivering breakthrough cellular health solutions
cdxc-20251106 - SEC. gov On November 6, 2025, the Company issued a press release announcing that the Board of Directors (the “Board”) of Niagen Bioscience, Inc (the “Company”) approved a share repurchase program (the “Share Repurchase Program”) authorizing the Company to repurchase up to $10 0 million of its common stock
ChromaDex Corporation - Name Symbol Change Option Symbol: CDXC New . . . ChromaDex Corporation (CDXC) will change its name and trading symbol to Niagen Bioscience, Inc (NAGE) effective March 19, 2025 As a result, option symbol CDXC will also change to NAGE effective at the opening of business on March 19, 2025
CDXC - Chromadex Corp Latest Stock News Market Updates Chromadex Corp (CDXC) is a globally recognized integrated nutraceutical and bioscience company committed to improving the quality of life through advanced research on healthy aging
ChromaDex Corp. Announces Name Change to Niagen Bioscience . . . - BioSpace ChromaDex Corp (NASDAQ:CDXC) is the global authority on nicotinamide adenine dinucleotide (NAD+), with a focus on the science of healthy aging The ChromaDex team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+